As of 2025-12-18, the Relative Valuation of Dechra Pharmaceuticals PLC (DPH.L) is (422.74) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 3,866.00 GBP, the upside of Dechra Pharmaceuticals PLC based on Relative Valuation is -110.9%.
The range of the Relative Valuation is (417.10) - (503.86) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.2x - 20.6x | 16.3x |
| Forward P/E multiples | 17.0x - 20.7x | 18.2x |
| Fair Price | (417.10) - (503.86) | (422.74) |
| Upside | -110.8% - -113.0% | -110.9% |
| Date | P/E |